carboplatin

The drug is used for the treatment of epithelial ovarian cancer and small cell lung cancer. It may be used either as a monotherapy or in combination with other antineoplastic agents.

Form: solution for injection

ATC: L01XA02

Manufacturer: Venus Remedies Limited

The drug is intended for adult patients for the treatment of progressive epithelial ovarian cancer (as both first-line and second-line therapy) and small cell lung cancer.

Form: concentrate for infusion solution

ATC: L01XA02

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used for the treatment of epithelial ovarian cancer and small cell lung cancer. It may be used either alone or in combination with other antineoplastic agents.

Form: concentrate for infusion solution

ATC: L01XA02

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (secondary packaging, labeling, quality control and batch release)

The drug is used as a monotherapy or in combination with other antineoplastic agents for the treatment of epithelial ovarian cancer and small cell lung cancer.

Form: concentrate for infusion solution

ATC: L01XA02

Manufacturer: Farmahemi B.V. (manufacturing of unpackaged product, primary and secondary packaging, batch control, batch release authorization)

The drug is used both as monotherapy and in combination with other agents for epithelial ovarian cancer and small cell lung cancer.

Form: solution for infusion

ATC: L01XA02

Manufacturer: Maylan Laboratories Limited (OTL)